Probing the binding pocket of the active site of aromatase with 2-phenylaliphatic androsta-1,4-diene-3,17-dione steroids

被引:9
作者
Takahashi, Madoka [1 ]
Yamashita, Kouwa [1 ]
Numazawa, Mitsuteru [1 ]
机构
[1] Tohoku Pharmaceut Univ, Aoba Ku, Sendai, Miyagi 9818558, Japan
关键词
Aromatase; Competitive inhibitor; Androsta-1,4-diene-3,17-dione; 2-Phenylaliphatic substituent; Suicide substrate; Breast cancer; HUMAN PLACENTAL AROMATASE; ENZYMATIC AROMATIZATION; BIOLOGICAL AROMATIZATION; ESTROGEN BIOSYNTHESIS; INHIBITORS; MECHANISM; CYTOCHROME-P-450; DELTA-1-TESTOLOLACTONE; ANDROSTENEDIONE; INACTIVATION;
D O I
10.1016/j.steroids.2010.01.008
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A series of 2-phenylaliphatic-substituted androsta-1,4-diene-3,17-diones (6) as well as their androstenedione derivatives (5) were synthesized as aromatase inhibitors to gain insights of structure-activity relationships of varying the alkyl moiety (C(1) to C(4)) of the 2-phenylaliphatic substituents as well as introducing a methyl- or trifluoromethyl function to p-position of a phenethyl moiety to the inhibitory activity. The inhibitors examined showed a competitive type inhibition. The 2-phenpropylandrosta-1,4-diene 6c was the most powerful inhibitor (K(i): 16.1 nM) among them. Compounds 6c along with the phenethyl derivative 6b caused a time-dependent inactivation of aromatase (k(inact): 0.0293 and 0.0454 min(-1) for 6b and 6c, respectively). The inactivation was prevented by the substrate androstenedione, and no significant effect of L-cysteine on the inactivation was observed in each case. Molecular docking of the phenpropyl compound 6c to aromatase was conducted to demonstrate that the phenpropyl group orients to a hydrophobic binding pocket in the active site to result in the formation of thermodynamically stable enzyme-inhibitor complex. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:330 / 337
页数:8
相关论文
共 43 条
[1]   Addition of hydrogen chloride and iodide to olefins - Undecenoic acid [J].
Abraham, EP ;
Smith, JC .
JOURNAL OF THE CHEMICAL SOCIETY, 1936, :1605-1607
[2]  
Akhtar M, 1997, J STEROID BIOCHEM, V61, P127
[3]  
Bossche H. Vanden, 1992, Journal of Steroid Biochemistry and Molecular Biology, V43, P1003, DOI 10.1016/0960-0760(92)90328-G
[4]   AROMATASE AND ITS INHIBITORS IN BREAST-CANCER-TREATMENT - OVERVIEW AND PERSPECTIVE [J].
BRODIE, AMH ;
SANTEN, RJ .
BREAST CANCER RESEARCH AND TREATMENT, 1994, 30 (01) :1-6
[5]  
COVEY DF, 1982, CANCER RES, V42, P3327
[7]  
COVEY DF, 1988, STEROID BIOSYNTHESIS, P534
[8]   Structural basis for androgen specificity and oestrogen synthesis in human aromatase [J].
Ghosh, Debashis ;
Griswold, Jennifer ;
Erman, Mary ;
Pangborn, Walter .
NATURE, 2009, 457 (7226) :219-U119
[9]   BIOSYNTHESIS OF ESTROGENS [J].
GUAL, C ;
GUT, M ;
MORATO, T ;
DORFMAN, RI ;
HAYANO, M .
ENDOCRINOLOGY, 1962, 71 (06) :920-&
[10]   Recent advances in the clinical application of aromatase inhibitors [J].
Harper-Wynne, C ;
Dowsett, M .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2001, 76 (1-5) :179-186